Isoprostane, an "intermediate phenotype" for oxidative stress: Heritability, risk trait associations, and the influence of chromogranin b polymorphism

Journal of the American College of Cardiology

Volumn 56, Issue 16, 2010, Pages 1338-1350

  Rao, Fangwen ^a   Zhang, Kuixing ^a   Khandrika, Srikrishna ^a   Mahata, Manjula ^a   Fung, Maple M ^a   Ziegler, Michael G ^a   Rana, Brinda K ^a   O'Connor, Daniel T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Catecholamine; CHGB; Hypertension; Isoprostane excretion; Metabolic syndrome; Oxidative stress; Twin study

Indexed keywords

ADRENALIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CATECHOLAMINE; CHROMOGRANIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOPROSTANE; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUCIFERASE; NORADRENALIN; TRIACYLGLYCEROL;

3' UNTRANSLATED REGION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHROMAFFIN CELL; DIASTOLIC BLOOD PRESSURE; DRUG EXCRETION; DYSLIPIDEMIA; GENE DISRUPTION; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRAIT; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEART RATE; HEREDITY; HERITABILITY; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PHENOTYPE; PLEIOTROPY; PRESSORECEPTOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN MOTIF; REPORTER GENE; RNA STABILITY; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHROMOGRANIN B; FEMALE; HUMANS; ISOPROSTANES; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, GENETIC;

EID: 77957376004     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.03.092     Document Type: Article

References (64)

1. I. Dalle-Donne, A. Scaloni, and D. Giustarini Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics Mass Spectrom Rev 24 2005 55 99
2. S. Lavi, E.H. Yang, and A. Prasad The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans Hypertension 51 2008 127 133
3. K.K. Griendling, D. Sorescu, and M. Ushio-Fukai NAD(P)H oxidase: role in cardiovascular biology and disease Circ Res 86 2000 494 501
4. R. Rodrigo, H. Prat, W. Passalacqua, J. Araya, C. Guichard, and J.P. Bachler Relationship between oxidative stress and essential hypertension Hypertens Res 30 2007 1159 1167
5. M. Gross, M. Steffes, and D.R. Jacobs Jr. Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study Clin Chem 51 2005 125 131
6. D. Pratico, L. Iuliano, and A. Mauriello Localization of distinct F2-isoprostanes in human atherosclerotic lesions J Clin Invest 100 1997 2028 2034
7. B. Wang, J. Pan, L. Wang, H. Zhu, R. Yu, and Y. Zou Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease Atherosclerosis 184 2006 425 430
8. F. Lacy, M.T. Kailasam, D.T. O'Connor, G.W. Schmid-Schonbein, and R.J. Parmer Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity Hypertension 36 2000 878 884
9. F. Lacy, D.T. O'Connor, and G.W. Schmid-Schonbein Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension J Hypertens 16 1998 291 303
10. L.E. Bautista Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence J Hum Hypertens 17 2003 223 230
11. J.S. Pankow, A.R. Folsom, and M. Cushman Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study Atherosclerosis 154 2001 681 689
12. L.J. Roberts II, and J.D. Morrow The generation and actions of isoprostanes Biochim Biophys Acta 1345 1997 121 135
13. J.D. Morrow, J.A. Awad, and T. Kato Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity An animal model of lipid peroxidation J Clin Invest 90 1992 2502 2507
14. J.D. Morrow, and L.J. Roberts The isoprostanes: unique bioactive products of lipid peroxidation Prog Lipid Res 36 1997 1 21
15. J.D. Morrow Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans Arterioscler Thromb Vasc Biol 25 2005 279 286
16. X. Hou, L.J. Roberts II, and D.F. Taber 2,3-Dinor-5,6-dihydro-15-F(2t)- isoprostane: a bioactive prostanoid metabolite Am J Physiol Regul Integr Comp Physiol 281 2001 R391 R400
17. S.H. Wilson, P.J. Best, L.O. Lerman, D.R. Holmes Jr., D.M. Richardson, and A. Lerman Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia Cardiovasc Res 44 1999 601 607
18. J.D. Krier, M. Rodriguez-Porcel, P.J. Best, J.C. Romero, A. Lerman, and L.O. Lerman Vascular responses in vivo to 8-epi PGF(2alpha) in normal and hypercholesterolemic pigs Am J Physiol Regul Integr Comp Physiol 283 2002 R303 R308
19. F. Martino, L. Loffredo, and R. Carnevale Oxidative stress is associated with arterial dysfunction and enhanced intima-media thickness in children with hypercholesterolemia: the potential role of nicotinamide-adenine dinucleotide phosphate oxidase Pediatrics 122 2008 e648 e655
20. G. Davi, P. Alessandrini, and A. Mezzetti In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia Arterioscler Thromb Vasc Biol 17 1997 3230 3235
21. J.F. Keaney Jr., M.G. Larson, and R.S. Vasan Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study Arterioscler Thromb Vasc Biol 23 2003 434 439
22. S. Devaraj, S.V. Hirany, R.F. Burk, and I. Jialal Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes Clin Chem 47 2001 1974 1979
23. C. Vassalle, N. Botto, M.G. Andreassi, S. Berti, and A. Biagini Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease Coron Artery Dis 14 2003 213 218
24. D.T. O'Connor, P.A. Insel, and M.G. Ziegler Heredity and the autonomic nervous system in human hypertension Curr Hypertens Rep 2 2000 16 22
25. D. Boomsma, A. Busjahn, and L. Peltonen Classical twin studies and beyond Nat Rev Genet 3 2002 872 882
26. D.S. Falconer, and T.F.C. Mackay Introduction to Quantitative Genetics, 4th ed 1996 Longman Essex, United Kingdom
27. P. Rosa, A. Hille, R.W. Lee, A. Zanini, P. De Camilli, and W.B. Huttner Secretogranins I and II: two tyrosine-sulfated secretory proteins common to a variety of cells secreting peptides by the regulated pathway J Cell Biol 101 1985 1999 2011
28. G. Falkensammer, R. Fischer-Colbrie, and H. Winkler Biogenesis of chromaffin granules: incorporation of sulfate into chromogranin B and into a proteoglycan J Neurochem 45 1985 1475 1480
29. Y.H. Huh, S.H. Jeon, and S.H. Yoo Chromogranin B-induced secretory granule biogenesis: comparison with the similar role of chromogranin A J Biol Chem 278 2003 40581 40589
30. K. Zhang, F. Rao, and B.K. Rana Autonomic function in hypertension: role of genetic variation at the catecholaminestorage vesicle protein chromogranin B (CHGB) Circ Cardiovasc Genet 2 2009 46 56
31. M. Cockburn, A. Hamilton, J. Zadnick, W. Cozen, and T.M. Mack The occurrence of chronic disease and other conditions in a large population-based cohort of native Californian twins Twin Res 5 2002 460 467
32. L. Zhang, F. Rao, and J. Wessel Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins Physiol Genomics 19 2004 277 291
33. J. Wessel, G. Moratorio, and F. Rao C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci J Hypertens 25 2007 329 343
34. T. Saito, S. Nanri, and I. Saito Reliability of family history of lifestyle-related diseases on questionnaire Pediatr Int 51 2009 514 519
35. J.T. Bensen, A.D. Liese, and J.T. Rushing Accuracy of proband reported family history: the NHLBI Family Heart Study (FHS) Genet Epidemiol 17 1999 141 150
36. F. Rao, G. Wen, and J.R. Gayen Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension Circulation 115 2007 2271 2281
37. N.R. Mahapatra, M. Mahata, and A.K. Datta Neuroendocrine cell type-specific and inducible expression of the chromogranin B gene: crucial role of the proximal promoter Endocrinology 141 2000 3668 3678
38. Z. Wang, G. Ciabattoni, and C. Creminon Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man J Pharmacol Exp Ther 275 1995 94 100
39. J. Proudfoot, A. Barden, and T.A. Mori Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry Anal Biochem 272 1999 209 215
40. B. Kennedy, and M.G. Ziegler A more sensitive and specific radioenzymatic assay for catecholamines Life Sci 47 1990 2143 2153
41. M. Stridsberg, B. Eriksson, K. Oberg, and E.T. Janson A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B Regul Pept 125 2005 193 199
42. M. Stridsberg Measurements of chromogranins and chromogranin-related peptides by immunological methods Adv Exp Med Biol 482 2000 319 327
43. G.M. Portela-Gomes, and M. Stridsberg Region-specific antibodies against chromogranin B display different immunoreactivity in the human pancreatic islet cell types Ann N Y Acad Sci 971 2002 341 344
44. M.A. Takiyyuddin, J.H. Cervenka, T. Dinh, J.L. Witztum, and D.T. O'Connor Selective alpha-blockade versus angiotensin-converting enzyme inhibition as initial antihypertensive therapy Effects on circulating lipoproteins Am J Med 86 1989 32 35
45. T.M. Wallace, J.C. Levy, and D.R. Matthews Use and abuse of HOMA modeling Diabetes Care 27 2004 1487 1495
46. K.A. Do, B.M. Broom, and P. Kuhnert Genetic analysis of the age at menopause by using estimating equations and Bayesian random effects models Stat Med 19 2000 1217 1235
47. L. Almasy, and J. Blangero Multipoint quantitative-trait linkage analysis in general pedigrees Am J Hum Genet 62 1998 1198 1211
48. SFBR SOLAR: Sequential Oligogenic Linkage Analysis Routines http://www.sfbr.org/Departments/genetics-detail.aspx?p=37 Accessed September 7, 2010
49. E. Halperin, and E. Eskin Haplotype reconstruction from genotype data using Imperfect Phylogeny Bioinformatics 20 2004 1842 1849 (Pubitemid 39199048)
50. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265
51. J. Tebo, S. Der, M. Frevel, K.S. Khabar, B.R. Williams, and T.A. Hamilton Heterogeneity in control of mRNA stability by AU-rich elements J Biol Chem 278 2003 12085 12093
52. C. Barreau, L. Paillard, and H.B. Osborne AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33 2005 7138 7150
53. M.N. Hinman, and H. Lou Diverse molecular functions of Hu proteins Cell Mol Life Sci 65 2008 3168 3181
54. L. Xiao, D.R. Pimentel, J. Wang, K. Singh, W.S. Colucci, and D.B. Sawyer Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes Am J Physiol Cell Physiol 282 2002 C926 C934
55. T. Bleeke, H. Zhang, N. Madamanchi, C. Patterson, and J.E. Faber Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species Circ Res 94 2004 37 45
56. K. Miyagawa, M. Ohashi, and S. Yamashita Increased oxidative stress impairs endothelial modulation of contractions in arteries from spontaneously hypertensive rats J Hypertens 25 2007 415 421
57. J.D. Morrow, K.E. Hill, R.F. Burk, T.M. Nammour, K.F. Badr, and L.J. Roberts II A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc Natl Acad Sci U S A 87 1990 9383 9387
58. B.M. Kromer, and J.R. Tippins Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha Br J Pharmacol 119 1996 1276 1280
59. X. Hou, F. Gobeil Jr., and K. Peri Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels Stroke 31 2000 516 524 ; discussion 525
60. R. Marley, D. Harry, R. Anand, B. Fernando, S. Davies, and K. Moore 8-Isoprostaglandin F2 alpha, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats Gastroenterology 112 1997 208 213
61. J.D. Morrow, B. Frei, and A.W. Longmire Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers Smoking as a cause of oxidative damage N Engl J Med 332 1995 1198 1203
62. B. Halliwell, and C.Y. Lee Using isoprostanes as biomarkers of oxidative stress: some rarely-considered issues Antioxid Redox Signal 13 2010 145 156
63. E.O. Lillie, and D.T. O'Connor Early phenotypic changes in hypertension: a role for the autonomic nervous system and heredity Hypertension 47 2006 331 333
64. N.R. Mahapatra, M. Mahata, S. Ghosh, J.R. Gayen, D.T. O'Connor, and S.K. Mahata Molecular basis of neuroendocrine cell type-specific expression of the chromogranin B gene: crucial role of the transcription factors CREB, AP-2, Egr-1 and Sp1 J Neurochem 99 2006 119 133